butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Struktur
2227199-31-5
CAS-Nr.
2227199-31-5
Englisch Name:
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
Synonyma:
Tofatinib Impurity 12;Tofacitib related impurities 40;N-Butyl 3-Oxopropanoate Tofacitinib;Butyl 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate;Butyl 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate;1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, butyl ester, (3R,4R)-;Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate (Tofacitinib Impurity)
CBNumber:
CB23956193
Summenformel:
C20H29N5O3
Molgewicht:
387.47596
MOL-Datei:
2227199-31-5.mol

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Eigenschaften

Dichte
1?+-.0.06 g/cm3(Predicted)
pka
13.31±0.50(Predicted)

Sicherheit

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Chemische Eigenschaften,Einsatz,Produktion Methoden

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 24)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ANHUI WITOP BIOTECH CO., LTD
+8615255079626
eric@witopchemical.com China 23556 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
ShenZhen H&D Pharmaceutical Technology Co., LTD
+86-0755-22677845 +86-13627253706
sale@hdimpurity.com China 2215 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 8011 55
TOSUN PHARM 020-61855200 13326451905
2881290884@qq.com China 7524 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 17825480238
3008233717@qq.com China 9843 12
Tianjin shijia biomedical technology co., LTD 15022261580;411316762
tjshj1212@163.com China 2359 58
Shenzhen ruikai de biotechnology co., ltd. 0755-61348847 17820674378
2682116078@qq.com China 7844 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 15850510341
shiqingran@wzxchem.com China 3567 58

2227199-31-5()Verwandte Suche:


  • Tofacitib related impurities 40
  • Butyl 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate
  • N-Butyl 3-Oxopropanoate Tofacitinib
  • Tofatinib Impurity 12
  • 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, butyl ester, (3R,4R)-
  • Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate (Tofacitinib Impurity)
  • Butyl 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
  • 2227199-31-5
Copyright 2019 © ChemicalBook. All rights reserved